An Epidemiological Cohort Study of Acute Coronary Syndromes in The Greek Population. The PHAETHON Study

Coronary Artery Disease Clinical Trial

— PHAETHON  

Official title:

An Epidemiological Cohort Study of Acute Coronary Syndromes in The Greek Population. The PHAETHON Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02420808
• Other study ID #: PHAETHON
• Status: Completed
• Phase: N/A
• First received: April 15, 2015
• Last updated: March 1, 2017
• Start date: March 2012
• Est. completion date: January 2014

Study information

• Verified date: March 2017
• Source: Hellenic Cardiovascular Research Society
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

A nationwide registry of patients with acute coronary disease to evaluate epidemiological patient characteristics, medical management, implementation of invasive strategy, patient outcome and impact on quality of life in Greece.

Description:

A nationwide registry of patients with acute coronary disease to evaluate epidemiological patient characteristics, medical management, implementation of invasive strategy, patient outcome and impact on quality of life in Greece.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 800
• Est. completion date: January 2014
• Est. primary completion date: June 2013
• Accepts healthy volunteers: No
• Gender: All
• Age group: 25 Years and older

Eligibility

Inclusion Criteria:

• Informed Consent

• > 25 years

• Admission in hospital within 24 hours from beginning of symptoms of transfer from antother hospital within 24 hours from beginning of symptoms.

• Acute Coronary Syndrom

Exclusion Criteria:

Related Conditions & MeSH terms

• Acute Coronary Syndrome
• Coronary Artery Disease
• Coronary Disease
• Myocardial Ischemia

Locations

Country	Name	City	State
Greece	General Hospital of Chalkida	Chalkida

Sponsors (1)

Lead Sponsor	Collaborator
Hellenic Cardiovascular Research Society

Country where clinical trial is conducted

Greece, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Evaluation of patients with Acute Coronary Syndromes.	Assessment of the epidemiological characteristics of patients who were hospitalized with a diagnosis of ACS. Evaluation of the therapeutic strategy and its outcome.	6 months
Secondary	Estimation of the percentage of patients.	Estimation of the percentage of patients who were hospitalized with STEMI, NSTEMI and unstable angina.	Baseline
Secondary	Description of the methods of patients' evacuation.	Description of the methods of patients' evacuation from the scene of the incident to the receiving hospital where was processed the treatment for ACS.	Baseline
Secondary	Estimation of the interval until the arrival in the hospital.	Estimation of the duration from the onset of pain until the arrival in the receiving hospital at various locations.	Baseline
Secondary	Evaluation of the blood test analysis during hospitalization.	Evaluation of hematological, biochemical parameters and myocardial necrosis markers during hospitalization.	Baseline
Secondary	Description of the administered medication.	Description of the pharmaceutical treatment administered during hospitalization and monitoring period.	Baseline - 6 months
Secondary	Evaluation of the male patients with erectile dysfunction.	Estimation of the percentage of the male patients with erectile dysfuction based to a predesigned questionnaire and investigation of the possible association with the treatment's outcome.	Baseline - 6 months